Kitazato Corporation (TYO:368A)

Japan · Delayed Price · Currency is JPY

1,356.00

-3.00 (-0.22%)

Jul 15, 2026, 2:11 PM JST

-27.87% (1Y)

Market Cap	54.36B
Revenue (ttm)	10.95B +6.3%
Net Income	3.90B +2.8%
EPS	97.38 +2.8%
Shares Out	40.00M
PE Ratio	13.96
Forward PE	13.59
Dividend	41.00 (3.02%)
Ex-Dividend Date	Mar 30, 2026

Volume	33,400
Open	1,352.00
Previous Close	1,359.00
Day's Range	1,343.00 - 1,358.00
52-Week Range	1,155.00 - 1,975.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company has strategic alliances with Repro Lifesciences LLP and establish a joint venture company in India for the purpose of strengthening regulatory compliance, market understanding, and customer support. The company was formerly known as Kitazato ... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1998

Employees 83

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 368A

Full Company Profile

Financial Performance

In fiscal year 2026, Kitazato's revenue was 10.95 billion, an increase of 6.26% compared to the previous year's 10.30 billion. Earnings were 3.90 billion, an increase of 2.82%.

Financial Statements